Literature DB >> 22072813

Starting with the ABCs: Akt in breast cancer.

Kip A West1, Phillip A Dennis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22072813     DOI: 10.1158/1535-7163.MCT-11-0712

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


× No keyword cloud information.
  1 in total

1.  Src Inhibition Can Synergize with Gemcitabine and Reverse Resistance in Triple Negative Breast Cancer Cells via the AKT/c-Jun Pathway.

Authors:  Zhen-Hua Wu; Chen Lin; Ming-Ming Liu; Jian Zhang; Zhong-Hua Tao; Xi-Chun Hu
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.